Cabazitaxel AqVida

Medicinal product

(Invented) name

Cabazitaxel AqVida

Active substance (s)

Kabazitakselis

Strength

20 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

Marketing authorisation holder

MB Metapharm, Lietuva

Date of authorisation

2025-09-04

Date of renewal

Documents

2833_Cabazitaxel AqVida_PZPL.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml koncentrato yra:	1 ml
Kabazitakselis	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118600	104703	1104703	flakonas	3 ml N1	ASPĮ	Receptinis	LT/L/25/2833/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-09-04	Registruotas